EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Newly discovered knowledge pertaining to glucagon and its clinical applications

Dan Kawamori iD, Shugo Sasaki

Journal of Diabetes Investigation · 2023

DOI: 10.1111/jdi.14009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes Investigation, 2023. Verfasst von Dan Kawamori und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Education Center, Faculty of Medicine, Osaka University, Osaka, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Glucagon-Secreting Cells. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science, and Technology in Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucagon has been defined as an ‘insulin counteracting hormone’, which raises blood glucose levels. Recent progress in basic research has shown that glucagon is closely involved in glucose and amino acid metabolism. Additionally, its secretion is intricately, but precisely, regulated by various mechanisms involving molecules in addition to glucose, thus showing its critical role in systemic nutrient metabolism. An innovative dual‐antibody‐linked immunosorbent assay for glucagon that improves measurement accuracy has been developed, and substantial clinical findings have been obtained using this new system. This discovery expanded the pathophysiological significance of glucagon and accelerated the development of its clinical applications in diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusGlucagon-Secreting CellsHumansGlucagonInsulinGlucoseBlood Glucose

Stichwörter der Autor:innen

Amino acids Glucagonα-Cells

Substanzen

GlucagonInsulinGlucoseBlood Glucose

Autor:innen und Institutionen

  • Medical Education Center, Faculty of Medicine, Osaka University, Osaka, Japan.
  • Postgraduate Medical Training Center, Osaka University Hospital, Osaka University, Osaka, Japan.
  • Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

ORCID-Profile: Dan Kawamori

Förderung

  • Ministry of Education, Culture, Sports, Science, and Technology in Japan

Zitieren

APA

Kawamori, D., & Sasaki, S. (2023). Newly discovered knowledge pertaining to glucagon and its clinical applications. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14009

Vancouver

Kawamori D, Sasaki S. Newly discovered knowledge pertaining to glucagon and its clinical applications. Journal of Diabetes Investigation. 2023. doi:10.1111/jdi.14009

BibTeX
@article{Kawamori2023,
  author = {Kawamori, Dan and Sasaki, Shugo},
  title = {Newly discovered knowledge pertaining to glucagon and its clinical applications},
  journal = {Journal of Diabetes Investigation},
  year = {2023},
  doi = {10.1111/jdi.14009}
}
Kostenlos starten →